1419 — Human Health Holdings Income Statement
0.000.00%
- HK$322.62m
- HK$17.26m
- HK$644.43m
- 89
- 95
- 26
- 84
Annual income statement for Human Health Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 655 | 1,122 | 1,002 | 591 | 644 |
Cost of Revenue | |||||
Gross Profit | 377 | 660 | 593 | 271 | 295 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 484 | 672 | 753 | 555 | 608 |
Operating Profit | 171 | 450 | 249 | 36.1 | 36.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 169 | 445 | 239 | 26.6 | 29.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 144 | 375 | 181 | 24.2 | 26.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 144 | 375 | 181 | 24.2 | 26.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 144 | 375 | 181 | 24.2 | 26.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.338 | 1 | 0.598 | 0.097 | 0.083 |
Dividends per Share |